Part 1 in our founder's guide to financing your women's health startup
What is keeping employers up at night going into 2025? A conversation with Chris Michalak
My takeaway from today’s news that the company is filing for bankruptcy
Guest author Halle Tecco’s breakdown of how the companies valued at more than $1b at the peak are faring — TLDR, the results surprised her!
A few thoughts...
And what are the pros and cons?
I caught up with Conceivable Life Sciences’ Joshua Abram to understand the political landscape and its impact on reproductive health
Some digital health companies are getting more targeted with their approach
Because so many of you asked for it!
Things have gotten a little better in digital health VC land, but it’s still challenging out there!
Health care VCs are flocking to AI - and it’s all starting to feel a lot like crypto
I teamed up with two health policy experts to explore the bull and bear case.
The company closed up shop abruptly this week.
Lessons learned after a strategy shift featuring Brightline CEO Naomi Allen and investor Alyssa Jaffee
With Tom Cassels, who’s sat on plenty of boards as an independent director
I’m introducing a new series to ask experts in the space tough questions about topics of the moment
Health care is a tough market, but there are invariably going to be big opportunities, according to Maveron's Jason Stoffer
Build for the needs of a community, not a single condition
RCM, transparency tools, HSA/FSAs and more
In this market, we're undervaluing and underestimating brick and mortar
Why we need a "systemic" solution to clinician burnout
The valuation may seem crazy, but it's actually not...
'This law could eliminate the friendly PC model in California as we know it'
Biotech is seeing a rebound, but health-tech is still in a bind
But it'll take private/public sector partnership to really move the needle
